NEUBASE THERAPEUTICS INC (NBSE)

US64132K2015 - Common Stock

0.378  -0.01 (-3.2%)

After market: 0.42 +0.04 (+11.11%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.